Trial Profile
Phase I/II study to assess the safety and efficacy of low doses of beta LT [beta-alethine] in patients with B-cell lymphoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Beta alethine (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 21 May 2021 Results presented at the 112th Annual Meeting of the American Association for Cancer Research
- 11 Oct 2005 New trial record.